குறி சூர்லேஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SMi Source™ Serves as the Core Disease Training Platform with Five of the Top Ten CROs

SMi Source™ Serves as the Core Disease Training Platform with Five of the Top Ten CROs
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jen pfauMark surlesMedical directorsகுறி சூர்லேஸ்மருத்துவ இயக்குநர்கள்

ScienceMedia Strikes Investment Deal with Decathlon Capital to Accelerate Clinical Education Platform

ScienceMedia Strikes Investment Deal with Decathlon Capital to Accelerate Clinical Education Platform Share Article Revenue-based financing deal will fund growth without any exchange of equity. “The imperative for swift, accurate and efficient clinical trials and advanced, cloud-based clinical training is more apparent than ever in the era of COVID-19,” said Mark Surles, CEO of ScienceMedia. SAN DEIGO (PRWEB) December 10, 2020 ScienceMedia, the leader in life sciences and clinical trial education, has agreed to terms on a major revenue-based financing investment with Decathlon Capital to support the continued growth of SMi Trial, the company’s clinical trial risk based protocol training platform.

John borchersMark surlesDecathlon capitalPalo altoDecathlon capital partnersCapital partnersPark cityஜான் போர்ச்சர்கள்குறி சூர்லேஸ்டெகாத்லான் மூலதனம்பாலோ ஆல்டோடெகாத்லான் மூலதனம் கூட்டாளர்கள்மூலதனம் கூட்டாளர்கள்பூங்கா நகரம்